CN104434776A - Meloxicam composition lyophilized tablet and preparation method thereof - Google Patents
Meloxicam composition lyophilized tablet and preparation method thereof Download PDFInfo
- Publication number
- CN104434776A CN104434776A CN201410736990.5A CN201410736990A CN104434776A CN 104434776 A CN104434776 A CN 104434776A CN 201410736990 A CN201410736990 A CN 201410736990A CN 104434776 A CN104434776 A CN 104434776A
- Authority
- CN
- China
- Prior art keywords
- meloxicam
- tablet
- solution
- hours
- starch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention provides a meloxicam composition lyophilized tablet and a preparation method thereof, and relates to the technical field of medicine and medicine production. The tablet is prepared from meloxicam, starch and sucrose, wherein the starch and sucrose are used as auxiliary materials, and common corn starch is subjected to heat process, so that adhesion and disintegration effects of the starch in a tablet can be improved, and the moldability of the tablet can be improved; and only starch and sucrose are needed in the meloxicam composition lyophilized tablet. According to the preparation method, a two-decreasing two-increasing lyophilizing process is adopted for the meloxicam composition lyophilized tablet, the moldability of the tablet can be better by means of twice cooling and twice heating, the solubility of the tablet can be improved, and the bioavailability of the tablet can be improved; the tablet is capable of overcoming the defect of conventional meloxicam tablets and reducing the types and usage of auxiliaries in the meloxicam tablets, is high in solubility and high in bioavailability, and can be used for guaranteeing the curative effect and safety of clinical administration.
Description
Technical field
The present invention relates to medicine and medical production technical field, be specifically related to a kind of meloxicam composition freeze-drying sheet and preparation method thereof.
Background technology
Meloxicam is the Transient conditions treatment of osteoarthritis symptoms when increasing the weight of; The long-term symptom treatment of rheumatoid arthritis and ankylosing spondylitis.
chemical structural formula
Molecular weight: 351.42
In common meloxicam tablet containing supplementary product kind and quantity more, generally to use filler, lubricant, disintegrating agent, adhesive, correctives etc., according to Chinese Pharmacopoeia (2010 editions) second meloxicam tablet quality standard, the dissolution of meloxicam tablet reached more than 75% for qualified 45 minutes time, and increasing research shows that impurity in the incompatibility of the toxic and side effects of adjuvant itself, adjuvant and principal agent, adjuvant etc. all can have an impact to the safety of medicine.
Therefore, provide one can overcome above-mentioned shortcoming, select suitable adjuvant and technique, reduce supplementary product kind and consumption in meloxicam tablet, improve dissolution and the bioavailability of meloxicam tablet, ensure that the safety of clinical application all has positive effect.
Traditional lyophilizing tablet can improve dissolution and bioavailability, but still need use the adjuvant such as mannitol, gelatin.And mannitol has certain biological activity, gelatin resource-constrained and perishable.
Starch is the basic adjuvant of oral solid formulation, it is polymerized by glucose molecule, and be commonly used for adhesive, diluent and disintegrating agent in tablets, it is cheap and easy to get, to human-body safety, but being used alone starch has no report as adjuvant freeze-dry process production meloxicam lyophilizing sheet.
Summary of the invention
Technical problem to be solved by this invention is the defect overcoming prior art, and propose a kind of meloxicam composition freeze-drying sheet and preparation method thereof further, said preparation adjuvant is few, good stability, and bioavailability is high.
Technical problem to be solved by this invention realizes by the following technical solutions:
A kind of meloxicam composition freeze-drying sheet, adjuvant is done with starch and sucrose, produce with freeze-dry process, this tablet overcomes the shortcoming of above-mentioned common meloxicam tablet, decrease supplementary product kind and consumption in meloxicam tablet, this sheet dissolution is large, and bioavailability is high, ensure that curative effect and the safety of clinical application.
A kind of meloxicam composition freeze-drying sheet, is prepared from by following raw material:
A preparation method for meloxicam composition freeze-drying sheet, comprises step as follows:
A, take the starch of component amount, add a certain amount of purified water and stir, by pH adjusting agent, the pH value of solution is controlled between 5-7.2, be then heated to 72 DEG C, be incubated 20 minutes, make the corn starch solution of 5 ~ 15% (W/V);
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution;
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, is down to room temperature and obtains Semen Maydis-sucrose solution;
D, take meloxicam 7.5 grams, add in 1L Semen Maydis-sucrose solution, stir 25 ~ 35 minutes;
Medicinal liquid is sub-packed in drug-containing dish after measuring meloxicam content by E, medicinal liquid, each drug-containing dish dress 1.0ml;
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs; Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain meloxicam composition freeze-drying sheet.
Described starch selects corn starch, preferably the corn starch solution of 10% (W/V).
Beneficial effect of the present invention is:
The preparation method of a kind of meloxicam composition freeze-drying sheet of the present invention, heating process process is carried out to common corn starch, starch bonding in tablets, disintegration can be improved, improve the mouldability of tablet, in meloxicam composition freeze-drying sheet, dosage of sucrose is 8.5% (W/V), it is the hardness reinforcer of this tablet, and plays flavored action.Meloxicam composition freeze-drying sheet only needs starch and sucrose two kinds of adjuvants.The freeze-dry process of two liters falls in meloxicam composition freeze-drying sheet employing two, and twice cooling, twice intensification can make sheet mouldability better, which increase the dissolution of tablet, thus improve the bioavailability of tablet.
Accompanying drawing explanation
Fig. 1 is the dissolution correlation curve figure of experiment Meloxicam.
Detailed description of the invention
The technological means realized to make the present invention, creation characteristic, reaching object and effect is easy to understand, below in conjunction with specific embodiment, set forth the present invention further, but following embodiment being only the preferred embodiments of the present invention, and not all.Based on the embodiment in embodiment, those skilled in the art under the prerequisite not making creative work obtain other embodiment, all belong to the protection domain of this patent.
Embodiment 1
A, take the corn starch of 100g, the purified water adding 900ml stirs, and controls at 5-7.2, is then heated to 72 DEG C, keep 120 minutes, make the corn starch solution of 9% (W/V) by pH adjusting agent by the pH value of solution.
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution.
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, after solution be down to room temperature obtain Semen Maydis-sucrose solution.
D, take meloxicam 7.5g, add in 1L Semen Maydis-sucrose solution, stir 30 minutes.
Medicinal liquid is sub-packed in drug-containing dish after measuring meloxicam content by E, medicinal liquid, each drug-containing dish dress 1.0ml.
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs.Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain meloxicam composition freeze-drying sheet.
Embodiment 2
A, take the corn starch of 130g, the purified water adding 900ml stirs, and controls at 5-7.2, is then heated to 72 DEG C, keep 120 minutes, make the corn starch solution of 13% (W/V) by pH adjusting agent by the pH value of solution.
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution.
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, after solution be down to room temperature obtain Semen Maydis-sucrose solution.
D, take meloxicam 7.5 grams (by 1000 calculations), add 1L Semen Maydis-sucrose solution, stir 30 minutes.
Medicinal liquid is sub-packed in drug-containing dish after measuring meloxicam content by E, medicinal liquid, each drug-containing dish dress 1.0ml.
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs.Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain meloxicam composition freeze-drying sheet.
Experimental data
The meloxicam composition freeze-drying sheet that above-described embodiment is obtained carries out following quality research test:
1, hardness, friability contrast test
Get meloxicam composition freeze-drying sheet prepared by above-described embodiment respectively and meloxicam ordinary tablet (commercially available) detects friability and hardness by " Chinese Pharmacopoeia " version in 2010 two annex X G inspection techniques, carried out comparative study, the results are shown in following table:
Sample | Hardness/N | Friability |
Embodiment 1 | 69 | <1% |
Embodiment 2 | 6.3 | <1% |
Ordinary tablet (commercially available) | 70.5 | <1% |
Experimental data shows, meloxicam composition freeze-drying sheet and ordinary tablet (commercially available) without significant difference, meet " Chinese Pharmacopoeia " version in 2010 to the requirement of tablet on friability and hardness.
2, dissolution contrast test
(No. 1 to No. 3 is embodiment 1 to get meloxicam tablet (commercially available) and each 6 of meloxicam composition freeze-drying sheet, No. 4 to No. 6 is embodiment 2), press Chinese Pharmacopoeia (2010 editions) second dissolution method annex X C second method respectively, with phosphate buffer (PH7.4) 900ml for dissolution medium, rotating speed is 75 turns per minute, operate in accordance with the law, respectively through 10min, 20min, 30min, 45min, during 75min, get solution to filter, get continuous worry liquid, according to Chinese Pharmacopoeia (2010 editions) second annex IV A ultraviolet visible spectrophotometry, absorbance is measured at the wavelength place of 362nm, another precision takes meloxicam reference substance and is about 20mg, accurately weighedly puts in 100mL measuring bottle, adds 0.1mol/L sodium hydroxide 10ml, excusing from death makes it dissolve, be diluted to scale with dissolution medium, shake up, precision measures 2ml, put (7.5mg specification) in 50ml measuring bottle, be diluted to scale with dissolution medium, shake up, in contrast solution, according to Chinese Pharmacopoeia (2010 editions) second annex IV A ultraviolet visible spectrophotometry, measure absorbance at the wavelength place of 362nm, calculate the stripping quantity of every sheet, result is as follows:
One, meloxicam tablet (commercially available)
Two, meloxicam lyophilizing sheet (No. 1 to No. 3 is embodiment 1, and No. 4 to No. 6 is embodiment 2)
Respectively with catch cropping Dissolution profiles during average dissolution pair, as Fig. 1.
Four, result judges
Judge according to Chinese Pharmacopoeia (2010 editions) second meloxicam tablet quality standard, the dissolution of meloxicam tablet (commercially available) reached more than 75% for qualified 45 minutes time, actual measurement is 76.35%, and meloxicam lyophilizing sheet dissolution 20 minutes time reaches 77.2%.It can thus be appreciated that the time that meloxicam lyophilizing sheet dissolution reaches 75% is than the time decreasing about 25 minutes of meloxicam tablet (commercially available).So the meloxicam lyophilizing sheet blood drug level peaking time is shorter than meloxicam tablet (commercially available), and bioavailability is higher, better efficacy.
More than show and describe ultimate principle of the present invention, principal character and advantage of the present invention.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; what describe in above-described embodiment and description is only preference of the present invention; be not used for limiting the present invention; without departing from the spirit and scope of the present invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the claimed scope of the invention.Application claims protection domain is defined by appending claims and equivalent thereof.
Claims (2)
1. a meloxicam composition freeze-drying sheet, is characterized in that, is prepared from by following raw material:
2. a preparation method for meloxicam composition freeze-drying sheet according to claim 1, is characterized in that, comprise step as follows:
A, take the starch of component amount, add a certain amount of purified water and stir, by pH adjusting agent, the pH value of solution is controlled between 5-7.2, be then heated to 72 DEG C, be incubated 20 minutes, make the corn starch solution of 5 ~ 15% (W/V);
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution;
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, is down to room temperature and obtains Semen Maydis-sucrose solution;
D, take meloxicam 7.5 grams, add in 1L Semen Maydis-sucrose solution, stir 25 ~ 35 minutes;
Medicinal liquid is sub-packed in drug-containing dish after measuring meloxicam content by E, medicinal liquid, each drug-containing dish dress 1.0ml;
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs; Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain meloxicam composition freeze-drying sheet.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410736990.5A CN104434776A (en) | 2014-12-05 | 2014-12-05 | Meloxicam composition lyophilized tablet and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410736990.5A CN104434776A (en) | 2014-12-05 | 2014-12-05 | Meloxicam composition lyophilized tablet and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104434776A true CN104434776A (en) | 2015-03-25 |
Family
ID=52882046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410736990.5A Pending CN104434776A (en) | 2014-12-05 | 2014-12-05 | Meloxicam composition lyophilized tablet and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104434776A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61242556A (en) * | 1985-04-19 | 1986-10-28 | Hatoya Seika:Kk | Preparation of snack using fruits |
US20020173016A1 (en) * | 2001-03-27 | 2002-11-21 | Helmut Wurst | High-throughput nucleic acid polymerase devices and methods for their use |
CN102579376A (en) * | 2011-01-14 | 2012-07-18 | 量子高科(北京)研究院有限公司 | Non-steroidal anti-inflammatory drug orally disintegrating tablet and producing method thereof |
-
2014
- 2014-12-05 CN CN201410736990.5A patent/CN104434776A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61242556A (en) * | 1985-04-19 | 1986-10-28 | Hatoya Seika:Kk | Preparation of snack using fruits |
US20020173016A1 (en) * | 2001-03-27 | 2002-11-21 | Helmut Wurst | High-throughput nucleic acid polymerase devices and methods for their use |
CN102579376A (en) * | 2011-01-14 | 2012-07-18 | 量子高科(北京)研究院有限公司 | Non-steroidal anti-inflammatory drug orally disintegrating tablet and producing method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104490750A (en) | Spirolactone composition freeze-dried tablets and preparation method thereof | |
CN104434837A (en) | Acetazolamide composition lyophilized tablet and preparation method thereof | |
CN104490828A (en) | Dexamethasone composition freeze-dried tablet and preparation method thereof | |
CN104490753A (en) | Furosemide composition freeze-dried tablet and preparation method thereof | |
CN104546766A (en) | Mercaptopurine composition freeze-drying tablet and preparation method thereof | |
CN104523629A (en) | Lisinopril composition freeze-dried tablets and preparation method thereof | |
CN104490759A (en) | Cobamamide composition freeze-dried tablets and preparation method thereof | |
CN104434776A (en) | Meloxicam composition lyophilized tablet and preparation method thereof | |
CN104586749A (en) | Metronidazole composition freeze-dried tablet and preparation method thereof | |
CN104546675A (en) | Estazolam composition freeze-dried tablet and preparation method thereof | |
CN104490830A (en) | Bezafibrate composition freeze-dried tablet and preparation method thereof | |
CN104490751A (en) | Hydrochlorothiazide composition freeze-dried tablets and preparation method thereof | |
CN104546683A (en) | Carbocisteine composition freeze-drying tablet and preparation method thereof | |
CN104546676A (en) | Cimetidine composition freeze-drying tablet and preparation method thereof | |
CN104546859A (en) | Dimenhydrinate composition freeze-dried tablets and preparation method thereof | |
CN104606153A (en) | Lyophilized perphenazine composition tablet and preparation method thereof | |
CN104473863A (en) | Benzbromarone composition lyophilized tablet and preparation method thereof | |
CN104546761A (en) | Acetaminophen composition freezing-drying tablet and preparation method thereof | |
CN104490755A (en) | Lyophilized tablet prepared from glyburide composition and preparation method thereof | |
CN104546751A (en) | Albendazole composition freeze-dried tablet and preparation method thereof | |
CN104434833A (en) | Melbine composition freeze-dried tablet and preparation method thereof | |
CN104546677A (en) | Inosine composition freeze-drying tablet and preparation method thereof | |
CN104434836A (en) | Lovastatin composition lyophilized tablet and preparation method thereof | |
CN104586790A (en) | Methotrexate composition freeze-dried tablet and preparation method thereof | |
CN104490758A (en) | Leflunomide composition freeze-dried tablets and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150325 |